SARS-CoV-2 (COVID-19) People, Projects and Publications Working on SARS-CoV-2 People Kate Grabowski Associate Professor, School of Medicine, Department of Epidemiology Emily Gurley Professor of the Practice, Departments of Epidemiology and International Health Sonia Tara Hegde Research Associate, Department of Epidemiology Alison Hill Assistant Professor, Department of Biomedical Engineering Elizabeth C. Lee Research Associate, Department of Epidemiology Shaun Truelove Assistant Scientist, Departments of Epidemiology and International Health Amy Wesolowski Assistant Professor, Department of Epidemiology Lauren Gardner Alton and Sandra Cleveland Professor, Department of Civil and Systems Engineering Clif McKee Research Associate, Department of Epidemiology Ensheng (Frank) Dong PhD Candidate, Department of Civil and Systems Engineering Hongru Du PhD Candidate, Department of Civil and Systems Engineering Kyra Grantz PhD Candidate, Department of Epidemiology Claire Smith PhD Candidate, Department of Epidemiology Andrew Azman Associate Scientist, Department of Epidemiology Saki Takahashi Assistant Professor, Department of Epidemiology Erica Carcelen Research Project Manager, Department of Epidemiology Anjalika Nande Postdoctoral Fellow, Institute for Computational Medicine Sara Loo Postdoctoral Fellow, Department of International Health, IVAC Anisha Oommen PhD Candidate, Department of Biomedical Engineering Max Marshall PhD Candidate, Center for Systems Science and Engineering Kristen Nixon PhD Candidate, Department of Civil and Systems Engineering Projects Human Mobility Modeling Through this project, we aim to model human mobility patterns and understand how travel impacts the spatial and temporal dynamics of various infectious diseases. Multi-Pathogen Scenario Modeling and Forecasting Integrating multiple models for short-term forecasts and longer-term scenario projections of multiple pathogens. Serological Modeling for Vaccine-Preventable Diseases (VPDs) Generating, analyzing, and modeling serological data on vaccine-preventable diseases (VPDs) and other infectious diseases to better understand vaccination coverage, transmission rates, and immunity gaps. Modeling Dynamic Disease-Behavior Feedbacks Integrating models of human behavior and decision making during epidemics into infectious disease transmission models. Center for Accelerating Modeling Utilization and Synthesis (CAMUS) Establishing centers of expertise in applied infectious disease modeling and advancing training programs for modelers, before the next pandemic. Publications January 2023 Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model study Borchering RK, et al. Lancet Reg Health Am Publication September 2022 Real-time COVID-19 forecasting: challenges and opportunities of model performance and translation Nixon K, et al. Lancet Digit Health Publication July 2022 The United States COVID-19 Forecast Hub dataset Cramer EY, et al. Sci Data Publication June 2022 Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination Truelove S, et al. Elife Publication June 2022 Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva Bouman JA, et al. Epidemics Publication June 2022 A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland Lorthe E, et al. Lancet Infect Dis Publication May 2022 SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan Moser W, et al. Emerg Infect Dis Publication April 2022 Why do some coronaviruses become pandemic threats when others do not? Rice BL, et al. PLoS Biol Publication April 2022 Ecology, evolution and spillover of coronaviruses from bats Ruiz-Aravena M, et al. Nat Rev Microbiol Publication April 2022 Author Correction: Ecology, evolution and spillover of coronaviruses from bats Ruiz-Aravena M, et al. Nat Rev Microbiol Publication April 2022 In-person schooling and associated COVID-19 risk in the United States over spring semester 2021 Wiens KE, et al. Sci Adv Publication April 2022 A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease Higdon MM, et al. Open Forum Infect Dis Publication April 2022 Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States Cramer EY, et al. Proc Natl Acad Sci U S A Publication April 2022 Modeling to Inform Economy-Wide Pandemic Policy: Bringing Epidemiologists and Economists Together Darden ME, et al. Publication April 2022 Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study Chen Z, et al. BMC Med Publication April 2022 Global landscape of SARS-CoV-2 genomic surveillance and data sharing Chen Z, et al. Nat Genet Publication March 2022 Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study Leidi A, et al. Clin Infect Dis Publication March 2022 Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis Chen X, et al. Clin Infect Dis Publication February 2022 Indirect effects of the early phase of the COVID-19 pandemic on the coverage of essential maternal and newborn health services in a rural subdistrict in Bangladesh: results from a cross-sectional household survey BMJ Open Publication February 2022 Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study Richard A, et al. Scand J Public Health Publication February 2022 SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March-June 2021 Bhuiyan TR, et al. Emerg Infect Dis Publication February 2022 Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study Leidi A, et al. Occup Environ Med Publication February 2022 High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh Hegde ST, et al. Emerg Infect Dis Publication January 2022 Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland Baysson H, et al. BMJ Open Publication View all diseases
Human Mobility Modeling Through this project, we aim to model human mobility patterns and understand how travel impacts the spatial and temporal dynamics of various infectious diseases.
Multi-Pathogen Scenario Modeling and Forecasting Integrating multiple models for short-term forecasts and longer-term scenario projections of multiple pathogens.
Serological Modeling for Vaccine-Preventable Diseases (VPDs) Generating, analyzing, and modeling serological data on vaccine-preventable diseases (VPDs) and other infectious diseases to better understand vaccination coverage, transmission rates, and immunity gaps.
Modeling Dynamic Disease-Behavior Feedbacks Integrating models of human behavior and decision making during epidemics into infectious disease transmission models.
Center for Accelerating Modeling Utilization and Synthesis (CAMUS) Establishing centers of expertise in applied infectious disease modeling and advancing training programs for modelers, before the next pandemic.
January 2023 Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model study Borchering RK, et al. Lancet Reg Health Am Publication
September 2022 Real-time COVID-19 forecasting: challenges and opportunities of model performance and translation Nixon K, et al. Lancet Digit Health Publication
June 2022 Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination Truelove S, et al. Elife Publication
June 2022 Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva Bouman JA, et al. Epidemics Publication
June 2022 A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland Lorthe E, et al. Lancet Infect Dis Publication
May 2022 SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan Moser W, et al. Emerg Infect Dis Publication
April 2022 Why do some coronaviruses become pandemic threats when others do not? Rice BL, et al. PLoS Biol Publication
April 2022 Ecology, evolution and spillover of coronaviruses from bats Ruiz-Aravena M, et al. Nat Rev Microbiol Publication
April 2022 Author Correction: Ecology, evolution and spillover of coronaviruses from bats Ruiz-Aravena M, et al. Nat Rev Microbiol Publication
April 2022 In-person schooling and associated COVID-19 risk in the United States over spring semester 2021 Wiens KE, et al. Sci Adv Publication
April 2022 A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease Higdon MM, et al. Open Forum Infect Dis Publication
April 2022 Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States Cramer EY, et al. Proc Natl Acad Sci U S A Publication
April 2022 Modeling to Inform Economy-Wide Pandemic Policy: Bringing Epidemiologists and Economists Together Darden ME, et al. Publication
April 2022 Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study Chen Z, et al. BMC Med Publication
April 2022 Global landscape of SARS-CoV-2 genomic surveillance and data sharing Chen Z, et al. Nat Genet Publication
March 2022 Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study Leidi A, et al. Clin Infect Dis Publication
March 2022 Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis Chen X, et al. Clin Infect Dis Publication
February 2022 Indirect effects of the early phase of the COVID-19 pandemic on the coverage of essential maternal and newborn health services in a rural subdistrict in Bangladesh: results from a cross-sectional household survey BMJ Open Publication
February 2022 Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study Richard A, et al. Scand J Public Health Publication
February 2022 SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March-June 2021 Bhuiyan TR, et al. Emerg Infect Dis Publication
February 2022 Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study Leidi A, et al. Occup Environ Med Publication
February 2022 High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh Hegde ST, et al. Emerg Infect Dis Publication
January 2022 Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland Baysson H, et al. BMJ Open Publication
